ConditionEyes & vision
Optic Glioma (Optic Pathway Glioma)
An optic glioma, or optic pathway glioma, is a usually slow-growing, low-grade tumor of the optic nerve or the visual pathways behind the eyes. Most occur in children under 10, and up to a third of affected children have neurofibromatosis type 1 (NF1). Many cause no symptoms and are found on screening; others cause vision loss, a bulging eye, a wandering eye or hormone problems. Many are simply monitored, and chemotherapy is used when vision is threatened.
Also called: Optic pathway glioma, optic nerve glioma, glioma of the optic nerve, optic pilocytic astrocytoma
At a glance
- What it is
- A low-grade glioma (usually pilocytic astrocytoma) of the optic nerve, chiasm or tracts.
- Who
- Mostly children under 10; about 15 percent of children with NF1 develop one.
- Symptoms
- Often none; vision loss, a bulging eye, squint, nystagmus, early puberty or growth problems.
- Diagnosis
- MRI of the brain and orbits; regular eye exams with visual acuity and fields.
- Treatment
- Observation if stable; chemotherapy or targeted MEK inhibitors if vision worsens; surgery or radiation rarely.
When to get help
Call 911 or go to the ER
- Severe headache with vomiting, drowsiness or a seizure: call 911 or your local emergency number
See a doctor within a day or two
- A rapid change in vision or a newly bulging eye in a child
- A child with NF1 who develops a new squint, eye wobbling or reduced vision
Book a routine appointment
- A child with NF1 who has not had a yearly eye exam
- Signs of early puberty before age 8 in girls or 9 in boys, or slowed growth, especially with NF1
- Poor vision noticed at school screening, or a child bumping into things on one side
What an optic glioma is
The optic nerves carry visual signals from each eye to the brain. They cross at the optic chiasm and continue as the optic tracts. Optic gliomas can arise anywhere along this pathway, from one optic nerve inside the eye socket to the chiasm, hypothalamus and beyond.
Most are pilocytic astrocytomas, a grade 1 glioma. They grow slowly and do not spread outside the nervous system.
Optic glioma and NF1
Neurofibromatosis type 1 is a genetic condition that causes café-au-lait spots, freckling in the armpits and groin, and benign nerve tumors. About 15 to 20 percent of children with NF1 develop optic pathway gliomas, usually before age 6. NF1-associated gliomas tend to be less aggressive, and many never cause problems. Children with NF1 have yearly eye exams so problems are caught early.
Optic glioma in adults
Rare. In older adults, an aggressive malignant optic glioma can cause rapid vision loss; it behaves very differently from the childhood form.
Symptoms
Symptoms depend on location and size:
- reduced vision in one or both eyes; young children rarely complain, so it may be noticed as clumsiness or bumping into things
- visual field loss
- a bulging eye (proptosis) when the tumor is in the eye socket
- squint (strabismus) or nystagmus (wobbling eyes)
- pale optic disc on eye exam
- hypothalamic or pituitary problems with chiasmal tumors: early puberty, poor growth, weight changes
- headache, vomiting and drowsiness if a large tumor blocks fluid flow in the brain
Diagnosis
- eye examination: visual acuity (age-appropriate testing), visual fields, color vision, optic nerve appearance, eye movements
- MRI of the brain and orbits with contrast: the key test; often diagnostic without biopsy, especially in NF1
- optical coherence tomography (OCT): measures the nerve fiber layer to track damage
- hormone tests for chiasmal or hypothalamic tumors
- biopsy: rarely needed, only if the appearance is unusual
- genetic testing for NF1 if not already known
Treatment
Treatment aims to preserve vision. Tumor size alone is not the main trigger; worsening vision is.
Observation
Many optic gliomas, especially in NF1, remain stable for years. Children are followed with regular eye exams and MRI scans.
Chemotherapy
The first-line active treatment, especially in young children:
- carboplatin and vincristine are the most common combination
- other regimens such as vinblastine for recurrence
Targeted therapy
- MEK inhibitors (such as selumetinib or trametinib) have shown good responses, particularly in NF1-associated and BRAF-altered tumors
- BRAF inhibitors (dabrafenib with trametinib) for tumors with a BRAF V600E mutation
Surgery
Rarely used, because it can damage vision. It may be considered for a blind, disfiguring bulging eye, or to relieve pressure on the brain.
Radiation
Generally avoided in young children and in NF1, because of long-term effects on the brain, hormones and blood vessels and a higher risk of second tumors. It may be used in older children with progressive disease.
Supportive care
- vision rehabilitation, low-vision aids and school support
- hormone replacement for pituitary problems
Outlook
Survival is excellent, especially for NF1-associated tumors. The main long-term issue is vision: some children keep good vision, while others have permanent loss in one or both eyes. Careful monitoring and timely treatment give the best chance of preserving sight.
Frequently asked questions
What is an optic glioma?
An optic glioma is a usually slow-growing, low-grade tumor of the optic nerve or the visual pathways in the brain. It mostly affects young children and is common in children with neurofibromatosis type 1.
What are the symptoms of optic glioma?
Symptoms can include reduced vision, visual field loss, a bulging eye, squint, wobbling eyes, and, with tumors near the hypothalamus, early puberty or growth problems. Many children, especially with NF1, have no symptoms.
Is optic glioma cancer?
Most childhood optic gliomas are low-grade tumors (pilocytic astrocytomas) that grow slowly and do not spread outside the nervous system. Survival is excellent, but they can damage vision. Rare adult forms can be aggressive.
How is optic glioma treated?
Many are monitored with eye exams and MRI. If vision worsens, chemotherapy (usually carboplatin and vincristine) or targeted MEK or BRAF inhibitors are used. Surgery and radiation are used only in specific situations.
Why do children with NF1 need eye exams?
About 15 to 20 percent of children with NF1 develop optic pathway gliomas, often before age 6 and often without symptoms. Yearly eye exams catch vision changes early so treatment can start before permanent loss occurs.
Sources
This guide was written from current patient and clinical guidance, including:
- National Cancer Institute: Childhood Astrocytomas and Other Gliomas Treatment (PDQ)
- Children's Tumor Foundation: Optic Pathway Gliomas in NF1
- American Academy of Ophthalmology (EyeWiki): Optic Nerve Glioma
- American Academy of Pediatrics: Health Supervision for Children with Neurofibromatosis Type 1
- National Organization for Rare Disorders (NORD): Optic Glioma